Drug profile · INN
mafenide acetate
MAFENIDE ACETATE
mafenide acetate (MAFENIDE ACETATE) is a bacterial dihydropteroate synthase inhibitor. Route of administration: topical. Current US regulatory status: approved.
Drug details — mafenide acetate
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
mafenide acetate (MAFENIDE ACETATE) is a bacterial dihydropteroate synthase inhibitor. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial dihydropteroate synthase inhibitor
Primary target: Dihydropteroate synthase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is mafenide acetate?
mafenide acetate (MAFENIDE ACETATE) is a bacterial dihydropteroate synthase inhibitor. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for mafenide acetate?
MAFENIDE ACETATE is a marketed brand name for mafenide acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mafenide acetate?
mafenide acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.